Your browser doesn't support javascript.
loading
Posterior reversible encephalopathy syndrome after bevacizumab treatment presenting to the ED as chest pain and headache.
Miller, A H; Monteiro de Oliveira Novaes, J A; Brock, P A; Sandoval, M.
Affiliation
  • Miller AH; University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030. Electronic address: ahmiller@mdanderson.org.
  • Monteiro de Oliveira Novaes JA; University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030.
  • Brock PA; University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030.
  • Sandoval M; University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030.
Am J Emerg Med ; 34(9): 1916.e1-2, 2016 Sep.
Article in En | MEDLINE | ID: mdl-26947375
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Posterior Leukoencephalopathy Syndrome / Bevacizumab / Antineoplastic Agents Type of study: Etiology_studies Limits: Female / Humans / Middle aged Language: En Journal: Am J Emerg Med Year: 2016 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Posterior Leukoencephalopathy Syndrome / Bevacizumab / Antineoplastic Agents Type of study: Etiology_studies Limits: Female / Humans / Middle aged Language: En Journal: Am J Emerg Med Year: 2016 Document type: Article